Education
About Us
Working with TipRanks
Follow Us
IQVIA Holdings Inc (IQV)
NYSE:IQV
IQV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$134.65 - $248.03
Previous CloseN/A
Volume300.39K
Average Volume (3M)1.24M
Market Cap
$31.61B
Enterprise Value$40.81B
Total Cash (Recent Filing)$2.19B
Total Debt (Recent Filing)$15.70B
Price to Earnings (P/E)26.9
Beta0.91
Next Earnings
Oct 22, 2025EPS Estimate
2.97Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.81
Shares Outstanding170,000,000
10 Day Avg. Volume1,209,541
30 Day Avg. Volume1,243,140
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.29
Enterprise Value/Revenue2.60
Enterprise Value/Gross Profit7.59
Enterprise Value/Ebitda12.19
Forecast
1Y Price Target
$215.08Price Target Upside15.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering16
Bulls Say, Bears Say
Bulls Say
Leadership TransitionThe CFO transition from Ron Bruehlman to Michael Fedock is expected to be seamless, enabling IQV to maintain its growth and investment strategies.
Legal ResolutionThe resolution between IQV and Veeva Systems removes a piece of uncertainty related to market incumbents.
Market StrategyIQV has been able to manage and drive-better-than-expected results in RDS by focusing on gaining share, particularly in biotech, and benefits from business diversification with strong TAS growth.
Bears Say
Margin PressureDespite topline results being ahead, margins compressed yoy, largely due to increase in FSP services and PTs in R&DS as well as revenue mix.
Pricing PressureIQV's willingness to bid on more business has come with an acceptance of lower pricing.
R&D Spending RiskA key risk for IQVIA is a slowdown in the R&D spending environment due to lower end-market pricing or other exogenous factors.
IQVIA Holdings News
IQV FAQ
What was IQVIA Holdings Inc’s price range in the past 12 months?
IQVIA Holdings Inc lowest stock price was $134.65 and its highest was $248.03 in the past 12 months.
What is IQVIA Holdings Inc’s market cap?
IQVIA Holdings Inc’s market cap is $31.61B.
When is IQVIA Holdings Inc’s upcoming earnings report date?
IQVIA Holdings Inc’s upcoming earnings report date is Oct 22, 2025 which is in 34 days.
How were IQVIA Holdings Inc’s earnings last quarter?
IQVIA Holdings Inc released its earnings results on Jul 22, 2025. The company reported $2.81 earnings per share for the quarter, beating the consensus estimate of $2.771 by $0.039.
Is IQVIA Holdings Inc overvalued?
According to Wall Street analysts IQVIA Holdings Inc’s price is currently Undervalued.
Does IQVIA Holdings Inc pay dividends?
IQVIA Holdings Inc does not currently pay dividends.
What is IQVIA Holdings Inc’s EPS estimate?
IQVIA Holdings Inc’s EPS estimate is 2.97.
How many shares outstanding does IQVIA Holdings Inc have?
IQVIA Holdings Inc has 170,000,000 shares outstanding.
What happened to IQVIA Holdings Inc’s price movement after its last earnings report?
IQVIA Holdings Inc reported an EPS of $2.81 in its last earnings report, beating expectations of $2.771. Following the earnings report the stock price went up 17.879%.
Which hedge fund is a major shareholder of IQVIA Holdings Inc?
Currently, no hedge funds are holding shares in IQV
IQVIA Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$215.08 (15.13% Upside)
$215.08 (15.13% Upside)
Blogger Sentiment
Bullish
IQV Sentiment 66%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 2.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.6%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-21.96%
12-Months-Change
Fundamentals
Return on Equity
19.80%
Trailing 12-Months
Asset Growth
8.46%
Trailing 12-Months
Company Description
IQVIA Holdings Inc
IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates in two primary segments: Technology & Analytics Solutions and Contract Research Services. IQVIA leverages its extensive healthcare data and insights to help clients accelerate drug development, optimize commercial strategies, and improve patient outcomes. Its core offerings include real-world evidence, clinical trial management, regulatory compliance, and market access solutions.
IQV Company Deck
IQV Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
IQVIA reported strong financial performance with record revenue and growth in key segments such as TAS, supported by advancements in AI and share repurchase activities. However, challenges persist in the form of an unsettled market environment, gross margin pressures, and elongated decision timelines for clinical projects.View all IQV earnings summariesIQV Revenue Breakdown
55.35% Research & Development Solutions
39.99% Technology & Analytics Solutions
4.66% Contract Sales & Medical Solutions
IQV Stock 12 Month Forecast
Average Price Target
$215.08
▲(15.13% Upside)
Technical Analysis
Ownership Overview
0.89% Insiders
24.84% Mutual Funds
31.77% Other Institutional Investors
16.65% Public Companies and
Individual Investors